Redefinition of positive CT result for lung cancer explored

Redefinition of positive CT result for lung cancer explored
Increasing the threshold for defining a positive result in computed tomography screening for lung cancer could reduce the need for further work-up but must be weighed against the potential for delayed diagnosis, according to a study published in the Feb. 19 issue of the Annals of Internal Medicine.

(HealthDay)—Increasing the threshold for defining a positive result in computed tomography (CT) screening for lung cancer could reduce the need for further work-up but must be weighed against the potential for delayed diagnosis, according to a study published in the Feb. 19 issue of the Annals of Internal Medicine.

To examine whether more restrictive thresholds would affect the frequency of positive results and lead to potential delays in the diagnosis of lung cancer, Claudia I. Henschke, Ph.D., M.D., of the Mount Sinai School of Medicine in New York City, and colleagues conducted a involving 21,136 participants with baseline CT screening. The current definition of positive result was any parenchymal, solid, or part-solid, noncalcified nodule of 5.0 mm or larger.

Using current thresholds, the researchers found that 16 percent of participants had a positive result. The frequency of positive results was 10.2, 7.1, 5.1, and 4.0 percent, respectively, for a threshold of 6.0, 7.0, 8.0, and 9.0 mm. The use of these higher thresholds would have correlated with reductions of 36, 56, 68, and 75 percent, respectively, in work-up. Lung cancer diagnoses would have been delayed by a maximum of nine months for 0, 5.0, 5.9, and 6.7 percent of cancer cases, respectively.

"The definition of positive result needs to be continually prospectively evaluated and updated in light of emerging evidence from on-going screening programs to reduce unnecessary surgery for nonmalignant pulmonary nodules and reduce potential harms of the diagnostic work-up, while maximizing the diagnosis and treatment of curable cases of ," the authors write.

Two authors have pending and issued patents, some of which are licensed to General Electric Healthcare. One author disclosed financial ties to .

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

PET outperforms CT in characterization of lung nodules

Feb 06, 2008

Researchers involved in a large, multi-institutional study comparing the accuracy of positron emission tomography (PET) and computed tomography (CT) in the characterization of lung nodules found that PET was far more reliable ...

Alternative PSA screening strategies could reduce harm

Feb 05, 2013

(HealthDay)—Compared with standard screening, alternative prostate-specific antigen (PSA) screening strategies could maintain good prostate cancer detection rates while reducing overdiagnoses and unnecessary ...

Recommended for you

User comments